Verastem, Inc. (VSTM)
5.53
-0.29
(-4.98%)
USD |
NASDAQ |
Mar 20, 16:00
5.54
+0.01
(+0.18%)
After-Hours: 20:00
Verastem Research and Development Expense (Quarterly) : 31.68M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Altimmune, Inc. | 18.38M |
| ADMA Biologics, Inc. | 1.376M |
| Ocugen, Inc. | 10.67M |
| Zevra Therapeutics, Inc. | 2.574M |
| Immuneering Corp. | 9.194M |